Omnicell, Inc. OMCL
35.90 USD -1.45 (-3.88%)
At closeNov 10, 2026, 4:05 PM EST
35.90 0.00 0.00%
After hours · Nov 10, 4:05 PM ET
34.96 Day range 37.06
31.75 52-week range 55.00
- YTD
- -20.75%
- 1 year
- -2.47%
News
zacks.com Buy These 3 Stocks with Broker Rating Upgrades for Big Gains Cinemark Holdings, Diamondback Energy and Omnicell stand out with recent broker rating upgrades and strong projected earnings growth for 2026.
zacks.com 4 Undervalued Stocks That Could Benefit from a Wall Street Rally Wall Street's rally puts undervalued stocks in focus. AVT, OMCL, HPE and LCUT stand out for attractive valuations, earnings growth prospects and upside potential.
zacks.com Why Omnicell (OMCL) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
defenseworld.net Contrasting Coloplast A/S (OTCMKTS:CLPBY) & Omnicell (NASDAQ:OMCL) Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and Omnicell (NASDAQ: OMCL - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses…
zacks.com Why Omnicell (OMCL) Might be Well Poised for a Surge Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com OMCL vs. VEEV: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking…
zacks.com Top Robotics Stocks With Strong Potential for Long-Term Growth Robotics is poised for robust long-term growth. Consider OMCL, SNPS, CDNS and MCHP for potential market dominance across sectors.
zacks.com Best Momentum Stocks to Buy for November 5th HTO, CR and OMCL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 5, 2026.
zacks.com Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect? The consensus price target hints at a 40.8% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings…
zacks.com New Strong Buy Stocks for November 5th HTO, SWKS, OMCL, CR and EXPD have been added to the Zacks Rank #1 (Strong Buy) List on November 5, 2026.
zacks.com Best Value Stocks to Buy for November 5th HTO, and OMCL made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 5, 2026.
zacks.com Why Omnicell (OMCL) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
benzinga.com Freedom Capital Markets Maintains Buy on Omnicell, Lowers Price Target to $55 Freedom Capital Markets analyst Gene Mannheimer maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $60 to $55.
seekingalpha.com Omnicell, Inc. (OMCL) Q3 2026 Earnings Call Transcript Omnicell, Inc. ( OMCL ) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT Company Participants David Unger - Vice President of Investor Relations Randall Lipps - Founder, Executive Chairman & CEO…
marketbeat.com Omnicell Q3 Earnings Call Highlights Omnicell NASDAQ: OMCL reported third-quarter 2026 revenue and non-GAAP EBITDA above the high end of its prior guidance, while executives said the company is preparing to begin shipments of its Titan…
zacks.com Here's What Key Metrics Tell Us About Omnicell (OMCL) Q3 Earnings While the top- and bottom-line numbers for Omnicell (OMCL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
benzinga.com Omnicell Q3 2026 Earnings Call Transcript Omnicell (NASDAQ:OMCL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Omnicell (OMCL) Q3 Earnings and Revenues Top Estimates Omnicell (OMCL) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.51 per share a year ago.
benzinga.com Omnicell Sees Q4 Adj EPS $0.41-$0.49 vs $0.37 Est; Sees Sales $295.000M-$301.000M vs $310.442M Est Omnicell (NASDAQ:OMCL) is looking for Q4 Adj EPS of $0.41-$0.49 vs $0.37 analyst estimate. sees sales of $295.000 million-$301.000 million vs $310.442 million analyst estimate.
benzinga.com Omnicell Raises FY2026 Adj EPS Guidance from $2.15-$2.30 to $2.48-$2.56 vs $2.27 Est; Narrows FY2026 Sales Guidance from $1.225B-$1.245B to $1.225B-$1.231B vs $1.237B Est Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $2.15-$2.30 to $2.48-$2.56 vs $2.27 analyst estimate. Narrows FY2026 sales outlook from $1.225 billion-$1.245 billion to $1.225…
benzinga.com Omnicell Q3 Adj. EPS $0.58 Beats $0.42 Estimate, Sales $307.851M Beat $304.474M Estimate Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.42 by 38.1 percent. This is a 13.73 percent increase over earnings of $0.51 per…
businesswire.com Omnicell Announces Third Quarter 2026 Financial Results FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Third Quarter 2026 Financial Results.
zacks.com Is This the Right Time to Retain Omnicell Stock in Your Portfolio? OMCL raises its 2026 earnings outlook on cost discipline and efficiency, but rising memory costs and delayed Titan XT adoption pose challenges.
defenseworld.net Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL) Omnicell (NASDAQ: OMCL - Get Free Report) and Baxter International (NYSE: BAX - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses…
businesswire.com Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026.- benzinga.com Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45 Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $45.
- benzinga.com Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50 Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.
benzinga.com Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65 Keybanc analyst Scott Schoenhaus maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $70 to $65.
benzinga.com Omnicell Sees Q3 Adj EPS $0.35-$0.43 vs $0.47 Est; Sees Sales $301.000M-$307.000M vs $312.528M Est Omnicell (NASDAQ:OMCL) is looking for Q3 Adj EPS of $0.35-$0.43 vs $0.47 analyst estimate. sees sales of $301.000 million-$307.000 million vs $312.528 million analyst estimate.- benzinga.com Omnicell Raises FY2026 Adj EPS Guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 Est; Narrows FY2026 Sales Guidance from $1.215B-$1.255B to $1.225B-$1.245B vs $1.248B Est Omnicell (NASDAQ:OMCL) raises FY2026 Adj EPS guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 analyst estimate. Narrows FY2026 sales outlook from $1.215 billion-$1.255 billion to $1.225…
- benzinga.com Omnicell Q2 Adj. EPS $0.94 Beats $0.47 Estimate, Sales $312.208M Beat $310.253M Estimate Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.47 by 100 percent. This is a 108.89 percent increase over earnings of $0.45 per…
- benzinga.com Omnicell Appoints COO Nnamdi Njoku As President, Effective July 1 Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell" or the "Company"), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Nnamdi Njoku has been
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Crude Oil Gains Over 3%; General Motors Earnings Top Views US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0.65%. GM reports better-than-expected Q1 results.
benzinga.com CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Earnings Scheduled For April 28, 2026 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Earnings Scheduled For February 5, 2026
benzinga.com This Airbnb Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Thursday 
benzinga.com Earnings Scheduled For October 30, 2025 - benzinga.com Earnings Scheduled For July 31, 2025
benzinga.com Advance Auto Parts Posts Upbeat Results, Joins Domo, LiveRamp, Urban Outfitters And Other Big Stocks Moving Higher On Thursday 
benzinga.com Earnings Scheduled For May 6, 2025 
benzinga.com Earnings Scheduled For February 6, 2025 - benzinga.com Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
benzinga.com Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday - benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 311 stocks hit new 52-week lows.